Newsletter - November 17, 2016
FDA’s Policy for Off-Label Promotion Takes a Deep Dive Public Discussion
Last week senior officials at FDA, including the FDA Commissioner, spent two full days listening and discussing their policy on regulation of off-label claims with stakeholders. The net result, no clear consensus and ongoing confusion about what the FDA may do next. About 70 speakers representing pharma and biotech companies, patient groups, industry...Read More
Predicting “Good” Employees in Technology Companies: Hiring Advise
What is the most productive age of an individual? Who is going to be more creative? Age-based discrimination in hiring practices is the most common reason for individuals being denied job opportunities, particularly when changing careers. Does the potential of individuals to do high-impact work depend on their age? Read More
FDA’s Policy for Off-Label Promotion Takes a Deep Dive Public Discussion
Last week senior officials at FDA, including the FDA Commissioner, spent two full days listening and discussing their policy on regulation of off-label claims with stakeholders. The net result, no clear consensus and ongoing confusion about what the FDA may do next. About 70 speakers representing pharma and biotech companies, patient groups, industry...Read More
Predicting “Good” Employees in Technology Companies: Hiring Advise
What is the most productive age of an individual? Who is going to be more creative? Age-based discrimination in hiring practices is the most common reason for individuals being denied job opportunities, particularly when changing careers. Does the potential of individuals to do high-impact work depend on their age? Read More
